Navigation Links
Beatrice Mintz, Ph.D., receives ninth annual AACR Award for Lifetime Achievement in Cancer Research
Date:3/29/2012

s authored more than 170 scientific publications, advancing our knowledge of developmental biology and genetics in cancer research. A member of the prestigious U.S. National Academy of Sciences since 1973, she has won numerous awards for pioneering research, including the Lewis S. Rosenstiel Award in Basic Medical Research, in 1980, the Genetics Society of America Medal, in 1981, the Ernst Jung Gold Medal for Medicine, in 1990, the American Cancer Society National Medal of Honor for Basic Research, in 1997, and in 2011, the Szent-Gyrgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research. She has been a member of numerous editorial boards and has received several honorary degrees.

Mintz earned a bachelor's degree from Hunter College of The City University of New York and a doctorate at the University of Iowa, in Iowa City.


'/>"/>

Contact: Diana Quattrone@fccc.edu
Diana.Quattrone@fccc.edu
215-815-7828
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist
2. AnaLisa DiFeo, Ph.D., recognized with the Liz Tilberis Scholarship
3. Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research
4. Yosef Shiloh, Ph.D., receives the 51st Annual AACR G.H.A. Clowes Memorial Award
5. Susan Band Horwitz, Ph.D., receives AACR Award for Lifetime Achievement in Cancer Research
6. Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research
7. 2010 AAAS Philip Hauge Abelson Award presented to the Honorable Rush Holt, Ph.D., for supporting science in Congress
8. Susan Band Horwitz, Ph.D., receives Eighth Annual AACR Award for Lifetime Achievement in Cancer Research
9. Yosef Shiloh, Ph.D., receives the 51st Annual AACR G.H.A. Clowes Memorial Award
10. Mayo Clinic: Raoul Tibes, M.D., Ph.D., to receive Career Development Award
11. Wyss Institute founding director, Donald Ingber, M.D., Ph.D., receives 2011 Holst Medal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... In an article published August 24th ... Global Open Journal that discusses the future of 3-D printing technology as it relates ... customized implants, prosthetics, and other 3-D printed tools could be used to aid in ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... Replacement Surgery Program at Monmouth, was one of the first doctors in the ... results of this new approach have been impressive: faster recovery, decreased immediate and ...
(Date:8/31/2015)... ... , ... Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center is ... all surgical and non-surgical disorders of the leg, ankle and foot. He also ... spine. , Dr. Paul Kovatis completed his orthopedic leg, ankle and foot fellowship training ...
(Date:8/31/2015)... ... August 31, 2015 , ... How can ... others—to hold down costs? , In a commentary for The American Journal ... the concept of “clinical efficacy,” which would bind parties together in agreements to ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... 2015 ABBY Awards, at the 16th Innovations in Healthcare(SM) Awards Event , ... Adaptive Business Leaders (ABL) Organization , recognizes innovative organizations and individuals who are ...
Breaking Medicine News(10 mins):Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 2Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 4Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 5Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 6Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 7Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 8
... DUBLIN, Ohio, Feb. 17 Cardinal Health today,announced it ... (FDA),on an amended consent decree regarding the company,s infusion ... has operated under a consent decree since February 2007,for ... implementing a new,quality system on April 2, 2008. Under ...
... too much TV is linked to poorer recall, study finds ... such as reading or playing games, in middle age and ... new research. , The study included 197 people, ages 70 ... and 1,124 people in the same age group with no ...
... Fla. Vitamin supplements can prevent hearing loss in ... one step closer to the development of a pill ... hearing loss in humans. , The findings will be ... annual conference in Baltimore by senior author Colleen Le ...
... INDIANAPOLIS, Feb. 17 WellPoint, Inc.,(NYSE: WLP ... webcast of its,Investor Conference on Tuesday, February 24, 2009. ... and chief executive officer of WellPoint, Inc.,and will feature ... The event is scheduled to ...
... 23 PERCENTSAN DIEGO, Feb. 17 Volcano Corporation (Nasdaq: ... manufacturing and sales of products for the diagnosis and ... that revenues for the full year 2008 increased 31 ... the fourth quarter of 2008 increased 23 percent over ...
... declines of up to 70 percent, CDC researchers say, ... caused by methicillin-resistant Staphylococcus aureus (MRSA) have ... the U.S. Centers for Disease Control and Prevention report. ... to certain antibiotics, can cause severe infections in people ...
Cached Medicine News:Health News:Cardinal Health, FDA Amend Infusion Pump Consent Decree 2Health News:Reading, Games Help Keep Aging Memories Sharp 2Health News:Vitamin supplements may protect against noise-induced hearing loss 2Health News:Vitamin supplements may protect against noise-induced hearing loss 3Health News:WellPoint Announces Webcast of its Conference with Investment Community 2Health News:Volcano Reports Full Year Revenues Increase 31 Percent 2Health News:Volcano Reports Full Year Revenues Increase 31 Percent 3Health News:Volcano Reports Full Year Revenues Increase 31 Percent 4Health News:Volcano Reports Full Year Revenues Increase 31 Percent 5Health News:Volcano Reports Full Year Revenues Increase 31 Percent 6Health News:Volcano Reports Full Year Revenues Increase 31 Percent 7Health News:Volcano Reports Full Year Revenues Increase 31 Percent 8Health News:Volcano Reports Full Year Revenues Increase 31 Percent 9Health News:Volcano Reports Full Year Revenues Increase 31 Percent 10Health News:Volcano Reports Full Year Revenues Increase 31 Percent 11Health News:Volcano Reports Full Year Revenues Increase 31 Percent 12Health News:Volcano Reports Full Year Revenues Increase 31 Percent 13Health News:Volcano Reports Full Year Revenues Increase 31 Percent 14Health News:MRSA Cases Dropping in Hospital ICUs 2Health News:MRSA Cases Dropping in Hospital ICUs 3Health News:MRSA Cases Dropping in Hospital ICUs 4
(Date:8/31/2015)... 31, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... field of regenerative medicine, today announced that the ... Chicago -based Rush University Medical Center in ... escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) in ... cervical spinal cord injury (SCI). This represents the ...
(Date:8/31/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... biopharmaceutical company focused on developing and commercializing novel ...
(Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
... in the New England ... and JACKSONVILLE, Fla., March 24 A study published ... Medicine suggests that intensive blood glucose (sugar) control ... does not improve outcomes and is associated with an ...
... 24 Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company ... of safety and efficacy data from the first cohort of ... recommended that Anthera,s Phase II clinical trial, known as the ... P hospholipase in A cute C hes ...
Cached Medicine Technology:Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 2Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 3Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 4Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 2Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 3
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products: